Madan Krishnan appointed as VP and MD of Boston Scientific for India Subcontinent

In this role, Madan will be responsible for the commercial business across India, Bangladesh, Bhutan, the Maldives, Nepal and Sri Lanka, as well as commercial operations and excellence across Asia Pacific

Boston Scientific has announced the appointment of Madan Krishnan as vice president and managing director, India Subcontinent and Commercial Operations/Excellence APAC, effective February 1, 2024. In this role, Madan will be responsible for the commercial business across India, Bangladesh, Bhutan, the Maldives, Nepal and Sri Lanka, as well as commercial operations and excellence across Asia Pacific.

Madan is an international business leader with more than two decades of progressive leadership experience in emerging and developed health care systems. He was previously with Medtronic, where he led the India business, and AstraZeneca where he held leadership roles based in Turkey, South Korea and Singapore. He takes over leadership of the India Subcontinent for Boston Scientific from Manoj Madhavan, who is relocating to the US to assume a global role within the company.

Stephen Morse, Senior Vice President and President, Asia Pacific, Boston Scientific said, “Madan brings rich experience of the health care sector to our business in India, where we have established a strong footprint and built a team that is dedicated to improving the health of patients in India as well as around the world. Madan’s wider commercial operations and excellence remit speaks to India’s medtech talent, and we are delighted that he joins us as we seek to become the highest-performing large cap medtech company.”

Commenting on his appointment, Krishnan said, “I am thankful to Boston Scientific for entrusting me with the responsibility to take forward the company’s mission in India. I look forward to leading and developing the local team and collaborating with colleagues around the world as we continue to transform lives through innovative medical solutions.”